Azacitidine in Treating Patients With Myelofibrosis

Clinical trial NCT00381693 · TERMINATED

Trial details

NCT number: NCT00381693
Sponsor: Mayo Clinic
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Secondary Myelofibrosis

Start date: 2006-08-01
Primary completion: 2008-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.